PROSPECT provides clinicians with supporting arguments for and against the use of various interventions in postoperative pain based on published evidence and expert opinion. Clinicians must make judgements based upon the clinical circumstances and local regulations. At all times, local prescribing information for the drugs referred to must be consulted.
Video-assisted thoracoscopic surgery (VATS) is a minimally invasive procedure allowing the reduction of surgical stress and postoperative pain compared with thoracotomy. However, it is associated with significant acute and chronic postoperative pain, which negatively affects recovery (Holbeck 2016; Bendixen 2016). Postoperative pain management for VATS is just as essential as it is for open surgery as it allows the reduction of postoperative complications (Bendixen 2016).
This guideline aims to provide clinicians with an evidence-based approach for pain management after pulmonary resection under VATS, to improve postoperative pain relief.
The unique PROSPECT methodology is available at http://esraeurope.org/prospect-methodology/.
COX, cyclooxygenase; ESPB, erector spinae plane block; FEV1, forced expiratory volume in the first second; IV, intravenous; NSAIDs, non-steroidal anti-inflammatory drugs; PVB, paravertebral block; TEA, thoracic epidural analgesia.
COX, cyclooxygenase; NSAIDs, non-steroidal anti-inflammatory drugs.
Analgesic interventions that are not recommended for pain management in patients undergoing VATS.
IV, intravenous; TENS, transcutaneous electrical nerve stimulation.
COX, cyclooxygenase; NSAID, non-steroidal anti-inflammatory drug.